参考文献/References:
[1] Ruiz-Cordero R,Devine WP.Targeted therapy and checkpoint immunotherapy in lung cancer[J].Surg Pathol Clin,2020,13(1):17-33.
[2] 刘 丽,武愫斌.双氧化酶成熟因子2基因检测在肺癌患者淋巴结转移及预后预测中的价值研究[J].陕西医学杂志,2022,51(8):1029-1032.
[3] Li MY,Liu LZ,Dong M.Progress on pivotal role and application of exosome in lung cancer carcinogenesis,diagnosis,therapy and prognosis[J].Mol Cancer,2021,20(1):22.
[4] Singh N,Baby D,Rajguru JP,et al.Inflammation and cancer[J].Ann Afr Med,2019,18(3):121-126.
[5] 孙 楠,李 源,孙守国,等.血液中炎症和脂质相关检测指标对非小细胞肺癌诊断价值的研究[J].中国肿瘤,2018,27(6):465-469.
[6] Huang JY,Larose TL,Luu HN,et al.Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the lung cancer cohort consortium(LC3)[J].Int J Cancer,2020,146(9):2394-2405.
[7] Olvera-Alvarez HA,Kubzansky LD,Campen MJ,et al.Early life stress,air pollution,infammation,and disease:An integrative review and immunologic model of social-environ-mental adversity and lifespan health[J].Neurosci Biobehav Rev,2018,92(0):226-242.
[8] Marozzi M,Parnigoni A,Negri A,et al.Inflammation,extracellular matrix remodeling,and proteostasis in tumor microenvironment[J].Int J Mol Sci,2021,22(15):8102.
[9] Giese MA,Hind LE,Huttenlocher A.Neutrophil plasticity in the tumor microenvironment[J].Blood,2019,133(20):2159-2167.
[10] 闫平钊,杨小花,王建华.中性粒细胞/淋巴细胞比值对Ⅱ期结直肠癌手术预后意义研究[J].陕西医学杂志,2018,47(6):751-754.
[11] 贾馨雨,郭治辰,孙 杨,等.CXC类趋化因子配体2通过募集肿瘤相关中性粒细胞促进肿瘤微环境中口腔鳞癌细胞侵袭能力的研究[J].实用口腔医学杂志,2021,37(5):660-665.
[12] 刘冬宇,白 劼,白红艳.肝细胞癌组织中Foxp3+调节性T淋巴细胞表达水平及其与肿瘤免疫相关性研究[J].陕西医学杂志,2021,50(8):1019-1022.
[13] Ward-Hartstonge KA,Kemp RA.Regulatory T-cell heterogeneity and the cancer immune response[J].Clin Transl Immunology,2017,6(9):e154.
[14] 陈 钢,段静静,苏 文,等.非小细胞肺癌患者外周血Th17淋巴细胞和白细胞介素17的表达及其意义[J].肿瘤研究与临床,2018,30(1):29-33.
[15] Zadka L,Grybowski DJ,Dziegiel P.Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance[J].Cell Oncol(Dordr),2020,43(4):539-575.
[16] 李君艳,陈国荣.肺癌患者凝血指标与临床特征的关系[J].陕西医学杂志,2019,48(6):718-721.
[17] 郑 凤,董星宇,李庆林,等.血小板促进肺癌细胞A549增殖与迁移的体外实验研究[J].临床肺科杂志,2022,27(1):74-78.
[18] Gao X,Yin J,Wang X,et al.A comprehensive comparison of hematological parameters among 39 common diseases[J].Scand J Clin Lab Invest,2019,79(4):251-259.
[19] 方申存,张映铭,张梅玲.中性粒细胞与淋巴细胞比率在评估晚期非小细胞肺癌患者预后的价值[J].临床肺科杂志,2018,23(7):1202-1204,1209.
[20] Xu F,Xu P,Cui W,et al.Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios may aid in identifying patientswith non-small cell lung cancer and predicting tumor-nodemetastasis stages[J].Oncol Lett,2018,16(1):483-490.
相似文献/References:
[1]朱志坚,孙丽芳,陆志刚 .外周血中性粒细胞/淋巴细胞比值对急性心肌梗死患者预后的预测价值[J].陕西医学杂志,2019,(10):1326.
ZHU Zhijian,SUN Lifang,LU Zhigang..Prognostic value of peripheral blood neutrophil/lymphocyte ratio for 〖JZ〗longterm prognosis in patients with acute myocardial infarction[J].,2019,(4):1326.
[2]杨凯祥,牛玉军.冠心病斑块易损性及预后与血小板/淋巴细胞比值及中性粒细胞/淋巴细胞比值相关性研究[J].陕西医学杂志,2021,50(1):44.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.011]
YANG Kaixiang,NIU Yujun.Correlation between plaque vulnerability,prognosis of coronary heart disease and PLR and NLR[J].,2021,50(4):44.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.011]